Updated on 30 June 2015
Mr Brian Jamieson, chairman, Sigma Pharmaceuticals
SIGMA PHARMACEUTICALS, Australia
Chairman: Mr Brian Jamieson
Revenue: $2722.8 mn
Business: Retail Pharmacy
Start-up Year: 1912
Sigma Pharmaceuticals, Australia's pharmaceutical retail and distribution entity that owns retail brands including Amcal, Amcal Max, Guardian, PharmaSave and Chemist King Drugstores, recorded a growth of 5.7 percent in 2014.
Strengthening its brand value, Sigma acquired Central Healthcare Services (CHS) and Discount Drug Stores (DDS) to bring a complementary business with a new wholesale distribution model for hospital sector.
Sigma Pharmaceuticals is currently focusing on efficient capital management and since October 2012, Sigma has undertaken a large and sustained on-market share buy-back program. The program recorded investment of $23.4 million in 2014.
To enhance its retail services, Sigma launched a pilot program for Click and Collect that enables customers to search and select products online and can later collect them from their closest pharmacy. Banking on online retail, Sigma plans to roll out the plan across the country this year.
Sigma generates the majority of its revenue from pharmaceutical wholesale activities and operation is spanned over 14000 products, 4000 pharmacies from 16 distribution centers across Australia.
According to Ibis world, Sigma retains almost 26 percent of the market share.